Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic CancerTalia Golan, Hedy L. Kindler, Pascal Hammel et al.|New England Journal of Medicine|2019Cited by 2.2k
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019Samir Gupta, Ndiya Ogba, Dawn Provenzale et al.|Journal of the National Comprehensive Cancer Network|2019Cited by 342
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic CancerHedy L. Kindler, Talia Golan, Daniel Hochhauser et al.|Journal of Clinical Oncology|2022Cited by 224
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017Samir Gupta, Ndiya Ogba, Dawn Provenzale et al.|Journal of the National Comprehensive Cancer Network|2017Cited by 215
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018Dawn Provenzale, Ndiya Ogba, Samir Gupta et al.|Journal of the National Comprehensive Cancer Network|2018Cited by 172